Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells

Life Sciences

Volumn 86, Issue 9-10, 2010, Pages 309-314

  Nakano, Miho ^a   Osada, Kenichi ^a   Misonoo, Atsushi ^b   Fujiwara, Keisuke ^a   Takahashi, Miho ^c   Ogawa, Yuriko ^a   Haga, Toshiaki ^a   Kanai, Shigeto ^a   Tanaka, Daisuke ^a   Sasuga, Yasuo ^a   Yanagida, Takuyoh ^a   Asakura, Mikio ^a   Yamaguchi, Noboru ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Oofuji Hospital   (Japan)

^c HBC Co Ltd   (Japan)

Author keywords

Akt; BDNF; Fluvoxamine; Phosphorylation; Sigma 1 receptor

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FLUVOXAMINE; PRASTERONE SULFATE; PROTEIN AKT 1; PROTEIN SERINE THREONINE KINASE; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; SERINE; SEROTONIN UPTAKE INHIBITOR; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL SURVIVAL; DEHYDROEPIANDROSTERONE SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUVOXAMINE; HUMANS; PC12 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, SIGMA; SERINE;

EID: 76849103674     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.11.017     Document Type: Article

References (32)

1. Altar C.A. Neurotrophins and depression. Trends in Pharmacological Sciences 1999, 20(2):59-61.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
3. Araki T., Yamada M., Ohnishi H., Sano S., Uetsuki T., Hatanaka H. Shp-2 specifically regulates several tyrosine-phosphorylated proteins in brain-derived neurotrophic factor signaling in cultured cerebral cortical neurons. Journal of Neurochemistry 2000, 74(2):659-668.
4. Barbacid M. Structural and functional properties of the TRK family of neurotrophin receptors. Annals of the New York Academy of Sciences 1995, 7:442-458.
5. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 2001, 50(4):260-265.
6. Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003, 38(2):157-160.
7. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 1997, 54(7):597-606.
8. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biological Psychiatry 2000, 48(8):732-739.
9. Elzbiet C., De-Maw C. Lithium activates the serine/ threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proceedings of the National Academy of Science 1999, 96(6):8745-8750.
10. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81(5):727-736.
11. Franke T.F., Kaplan D.R., Cantley L.C. PI3K: downstream action blocks apoptosis. Cell 1997, 88(4):435-437.
12. Franke T.F., Kaplan D.R., Cantley L.C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3, 4-bisphosphate. Science 1997, 275(5300):665-668.
13. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research Reviews 2004, 45(2):104-114.
14. Hayashi T., Hayashi T., Su T.P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:491-496.
15. Marte B.M., Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends in Biochemical Sciences 1997, 22(9):355-358.
16. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34(1):13-25.
17. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., Robbins T., Winsky L., Zalcman S. Preclinical models: status of basic research in depression. Biological Psychiatry 2002, 52(6):503-528.
18. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. The Journal of Neuroscience 1995, 15(11):7539-7547.
19. Nibuya M., Takahashi M., Russell D.S., Duman R.S. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neuroscience Letters 1999, 267(2):81-84.
20. Nishimura T., Ishima T., Iyo M., Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS ONE 2008, 3(7):1-9.
21. Russo-Neustadt A.A., Beard R.C., Huang Y.M., Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000, 101(2):305-312.
22. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., Castrén E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. The Journal of Neuroscience 2003, 23(1):349-357.
23. Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992, 9(3):383-391.
24. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. The Journal of Neuroscience 2002, 22(8):3251-3261.
25. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacology, Biochemistry, and Behavior 1997, 56(1):131-137.
26. Skolnick P. Antidepressants for the new millennium. European Journal of Pharmacology 1999, 375(1-3):31-40.
27. Smith M.A., Makino S., Kim S.Y., Kvetnansky R. Stress increases brain-derived neurotrophic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology 1995, 136(9):3743-3750.
28. Smith M.A., Makino S., Kvetnansky R. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. The Journal of Neuroscience 1995, 15(3 Pt 1):1768-1777.
29. Thakker DR, Natt F, Huske D, van der Putten H, Maier R, Hoyer D, Cryan JF. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Molecular Psychiatry 10(8), 782-789, 714, 2005.
30. Weiss E.R., Maness P., Lauder J.M. Why do neurotransmitters act like growth factors?. Perspectives on Developmental Neurobiology 1998, 5(4):323-335.
31. Yagasaki Y., Numakawa T., Kumamaru E., Hayashi T., Su T.P., Kunugi H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. The Journal of Biological Chemistry 2006, 281(18):12941-12949.
32. Zhou M., Enge K., Wang J. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochemical Pharmacology 2006, 73(1):147-154.